Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen Shrugs Off Turkish Price Cuts, Snatches Up Mustafa Nevzat For Broader Reach Into Emerging Markets

This article was originally published in PharmAsia News

Executive Summary

Despite harsh price cuts in Turkey that have taken a toll on multinationals, Amgen dives head first into the market.

Advertisement

Related Content

Amgen Hits Another Emerging Market Target With $700M Turkish Deal
With December Approaching, Are More Turkish Price Cuts On The Way?
Lilly Among MNCs Scouting In Turkey For Local Partners As GMP Inspection Backlog Continues
What Pricing Pressure? Recordati Continues Push Into Turkey With Latest Acquisition
Boehringer Threatens Turkish Exit Due To Price Cuts
After Brazil Onto China? Amgen Unveils Emerging Market Strategy
GSK Reportedly Bidding For Turkish Biofarma, Local Manufacturing Key To Market Registration

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC080924

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel